September/October 2022
Biopharma Asia
September/October 2022 | Volume 11 Issue 5
Commercial Cell Therapy Experience Using Mycoplasma NAT For Product Release: Five-Year Rev...
Adam Barron, Director, Research & Development Mark Troddyn, Quality Control Profession...
Best Practices of Downstream Protein Purification and Product Concentration
Krishnamurthy Venkatesan, Downstream MSAT Lead, Senior Director Biocon Biologics
Chromatography Based Near-Real-Time Measurements & Control of Product Titer, Product ...
Dr. Letha Chemmalil, Scientific Associate Director Dr. Chis Chumsae, Director of Analytica...
The Exogenously Driven Disruption of Bioprocessing by Industry 4.0
Christos Varsakelis, Team Lead Artificial Intelligence/Machine Learning, The Janssen Pharm...
Automation Supports Process Safety, Real-time, quality-driven control over complex process...
Martin Gadsby, Vice President, Optimal Industrial Automation Ltd
The Power of Modular Design
Hana Selvey, Technical Writer, Pall Corporation
















